Colon Cancer

Home / Colon Cancer

Colorectal Cancer

Colorectal cancer (CRC) is the third most common cancer diagnosed in the United States. Unfortunately, up to 20% of new CRC cases have metastases at the time of diagnosis. The most common sites of metastatic disease in CRC are the liver, lung, and peritoneum. Close to 5% of patients with CRC will present with peritoneal carcinomatosis (PC).

One of the many challenges of treating PC in stage IV CRC patients is drug delivery. It is often difficult to attain adequate drug levels within the peritoneum. If chemotherapy doses are subsequently increased in attempts to raise drug concentrations, the patient is exposed to more systemic side effects. HIPEC aims to deliver chemotherapy directly to the peritoneum, which can increase local drug concentrations, as well as reduce the total systemic exposure from the chemotherapy.

CRS and HIPEC do appear to have promising data when used in the optimal patient population. It is important, when considering CRS and HIPEC, that a patient reviews an institution’s experience with this collaborative treatment approach.

Daniel: Metastatic Colon Cancer

Dr. Fabian Johnston HIPEC: What You Need to Know

Dr. Byrne Lee focuses on the treatment of gastrointestinal cancer

Dr. George Salti

Treatment featured on Good Doctor available in Goshen

Hyperthermic Intraperitoneal Chemotherapy Performed At Memorial Healthcare System

Schedule a Conversation with a Surgeon

Would you like to browse our full surgeon database and locate a Surgical Oncologist/Gynecological Oncologist in your area?

Patient Stories

Would you like to browse our full surgeon database and locate a Surgical Oncologist/Gynecological Oncologist in your area?

Heated Chemotherapy After Surgery Greatly Extends Lives

Heated Chemotherapy After Surgery Greatly Extends Lives of Patients with Some Advanced Colorectal Cancers The past several years of cancer research have been both exciting and promising. Recent developments have allowed us to take steps in improving many cancer treatments. I believe this momentum will continue to accelerate exponentially. One research project that has offered us considerable hope was a study my colleagues and I conducted between 2003 and 2011. We looked at our results of 112 patient cases to see the immediate and long-term effects of, at the time, a newly developed procedure. The procedure, cytoreductive surgery combined with...

Read More

HIPEC and Appendiceal Cancer: One Patient’s Story

10/01/2012 Appendiceal carcinoma, pseudomyxoma peritonei (PMP)* and other peritoneal surface malignancies are rare and, sadly, all too often misdiagnosed or poorly managed. Just ask Joseph Laureanno, a 53-year-old sales executive from Lowell. “I’d been having some discomfort in my lower right abdomen,” he recalls. “So when I went for my regular wellness checkup with my PCP, he sent me for a CT, thinking I might have a gallstone.” “Based on the CT, however, they thought I might need an appendectomy but were concerned about the fluid they saw in my abdomen,” he continues. “They suggested I go by ambulance to...

Read More